Gaxos.ai Partners with BytePlus to Enhance AI Capabilities
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Feb 19 2026
0mins
Should l Buy GXAI?
Source: Benzinga
Gaxos.ai Inc. shares surged by 17.07% as the stock crossed above its 20-day SMA, reflecting strong investor interest following a significant partnership announcement.
The company has finalized a strategic partnership with BytePlus, the enterprise technology division of ByteDance, which is expected to enhance Gaxos' AI capabilities and accelerate the deployment of AI tools in its flagship platform, Art-Gen. This collaboration will provide Gaxos with preferred pricing and discounts on advanced video generation models, improving gross margins and solidifying its competitive edge in the rapidly growing creator economy.
This partnership not only positions Gaxos.ai for rapid market penetration but also reflects strong market confidence in the company's growth potential, especially in the AI sector. The stock's impressive rise amidst a generally weak market indicates a positive outlook for Gaxos.ai.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy GXAI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on GXAI
About GXAI
Gaxos.ai Inc. is a technology-based company. The Company is focused on addressing health, longevity, and entertainment, through artificial intelligence (AI) solutions. The Company's offerings include health, wellness and gaming. Its flagship product is its gaming platform called Gaxos (Gaxos Gaming), created to develop, design, acquire, and manage conventional games and to combine these games with unconventional game mechanisms, such as the ability for gamers and developers to utilize artificial intelligence to create and design in-game features, as well as to mint in-game features, such as skins, characters, weapons, gear, levels, and virtual lands, in the form of non-fungible tokens (NFTs) that allows users to have experiences and more control over in-game assets. Its Gaxos Health integrates AI-driven insights with individual biometric data and health goals to create Web and application based personalized wellness strategies for users.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Gaxos.ai Partners with Byteplus to Enhance AI Capabilities
- Partnership Enhances AI Capabilities: Gaxos.ai has partnered with Byteplus, the Enterprise Technology Division of ByteDance, which is expected to significantly enhance Gaxos' AI capabilities and accelerate the deployment of AI tools in its flagship platform, Art-Gen, thereby improving its market penetration in the rapidly growing creator economy.
- Preferred Pricing Strategy: Under the agreement, Gaxos will receive preferred pricing and discounts on ByteDance's advanced video generation models, which not only helps to improve Gaxos' gross margins but also accelerates its technology application, further solidifying its competitive edge in the AI space.
- Short-Term Trading Trend Analysis: Gaxos.ai is currently trading 3.9% below its 20-day simple moving average and 8.1% above its 50-day moving average, reflecting a mixed short-term trading trend, with shares decreasing by 23.60% over the past 12 months.
- Technical Indicator Interpretation: The current Relative Strength Index (RSI) stands at 48.78, indicating neutral territory, while the MACD is at -0.0078, below its signal line at 0.0201, suggesting bearish pressure on the stock, and the combination of these indicators reflects the complexity of market momentum.
See More
Pitney Bowes Q4 Earnings Beat Expectations, Shares Surge
- Earnings Surprise: Pitney Bowes reported an adjusted EPS of 45 cents for Q4, surpassing the analyst consensus of 38 cents, indicating strong profitability and boosting investor confidence.
- Sales Miss: The quarterly sales of $478 million fell short of the expected $486.68 million, highlighting some market demand challenges that could impact future revenue growth.
- Stock Surge: The company's shares jumped 7.9% to $11.05 in pre-market trading, reflecting optimistic market sentiment regarding its future prospects and potentially attracting more investor interest.
- Positive Guidance: Pitney Bowes issued FY26 adjusted EPS guidance with a midpoint above estimates, further strengthening market confidence in its long-term growth potential.
See More
U.S. Stocks Mostly Lower, Nasdaq Drops Over 50 Points
- Market Performance: U.S. stocks traded mostly lower on Tuesday, with the Nasdaq Composite falling over 50 points, and the S&P 500 dropping 0.13% to 6,827.16, indicating a cautious investor sentiment amid market weakness.
- Company Highlights: Medtronic PLC (NYSE:MDT) reported an adjusted EPS of $1.36 for Q3, exceeding market expectations of $1.33, with quarterly sales of $9.017 billion surpassing the $8.905 billion forecast, showcasing the company's strong earnings capability.
- Sector Dynamics: Financial shares gained 0.9%, while materials stocks fell by 2%, reflecting a divergence in market performance as investors may be seeking more defensive investment opportunities amidst volatility.
- Economic Indicators: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, up from 7,750 in the previous period, indicating an improving labor market trend.
See More
Kraig Biocraft Laboratories Shifts to Production Phase
- Production Strategy Shift: Kraig Biocraft Laboratories announced its 2026 production strategy has officially transitioned into execution mode, targeting a monthly output of 10 metric tons of recombinant spider silk cocoons, marking an ambitious scale-up in the advanced materials market.
- Commercialization Progress: This production shift is seen as a pivotal step from planning to production, expected to drive sustainable supply contracts and downstream revenue visibility, thereby enhancing market competitiveness.
- AI Technology Partnership: Gaxos.ai finalized a deal with BytePlus, securing preferred pricing and early access to advanced video generation models, which is anticipated to enhance deployment speed and gross margins for its AI video tools.
- Enterprise Security Expansion: Bond completed a one-year pilot with one of the world's largest employers, and if converted into a broader rollout, it could generate over $10 million in annual revenue, highlighting its growth potential in the corporate security sector.
See More
Gaxos.ai Partners with ByteDance to Enhance AI Capabilities
- Strategic Partnership: Gaxos.ai has finalized a partnership with ByteDance's enterprise technology unit, BytePlus, securing preferred pricing and discounts on advanced video generation models, which will accelerate the integration of AI tools into its Art-Gen platform and significantly enhance market competitiveness.
- Cost Reduction: This collaboration is expected to lower infrastructure costs and improve scalability for Gaxos.ai, which in turn is projected to enhance gross margins and drive profitability across its AI solutions in health, wellness, and gaming sectors.
- Stock Surge: Following the announcement of the partnership with ByteDance, Gaxos.ai's shares surged nearly 55% in opening trades, indicating strong market confidence in the strategic collaboration and reflecting investor optimism about the company's growth potential.
- AWS Funding Support: Gaxos.ai also received funding from Amazon Web Services (AWS) for its AI-powered sales coaching platform, Gaxos Labs, which is expected to enhance platform security and operational efficiency through features like real-time call transcription and automated coaching insights.
See More
U.S. Stocks Show Mixed Performance in Morning Trading
- Dow Jones Index Gains: On Tuesday, the Dow Jones index rose approximately 0.1%, trading up 0.06% to 49,529.45 points after the market opened, indicating a mild optimistic sentiment despite mixed overall performance.
- NASDAQ and S&P 500 Performance: The NASDAQ fell 0.03% to 22,540.83 points, while the S&P 500 gained 0.04% to 6,838.63 points, reflecting a divergence between tech stocks and blue-chip stocks, prompting investors to monitor sector dynamics closely.
- Manufacturing Index Decline: The NY Empire State Manufacturing Index dropped to 7.1 in February from 7.7 in January and below the market estimate of 7, indicating a slowdown in manufacturing activity that could impact overall economic growth expectations.
- Improved Employment Data: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, compared to 7,750 in the prior period, suggesting a gradual recovery in the labor market.
See More
Gaxos.ai Partners with Byteplus to Enhance AI Capabilities
- Partnership Enhances AI Capabilities: Gaxos.ai has partnered with Byteplus, the Enterprise Technology Division of ByteDance, which is expected to significantly enhance Gaxos' AI capabilities and accelerate the deployment of AI tools in its flagship platform, Art-Gen, thereby improving its market penetration in the rapidly growing creator economy.
- Preferred Pricing Strategy: Under the agreement, Gaxos will receive preferred pricing and discounts on ByteDance's advanced video generation models, which not only helps to improve Gaxos' gross margins but also accelerates its technology application, further solidifying its competitive edge in the AI space.
- Short-Term Trading Trend Analysis: Gaxos.ai is currently trading 3.9% below its 20-day simple moving average and 8.1% above its 50-day moving average, reflecting a mixed short-term trading trend, with shares decreasing by 23.60% over the past 12 months.
- Technical Indicator Interpretation: The current Relative Strength Index (RSI) stands at 48.78, indicating neutral territory, while the MACD is at -0.0078, below its signal line at 0.0201, suggesting bearish pressure on the stock, and the combination of these indicators reflects the complexity of market momentum.
See More
Pitney Bowes Q4 Earnings Beat Expectations, Shares Surge
- Earnings Surprise: Pitney Bowes reported an adjusted EPS of 45 cents for Q4, surpassing the analyst consensus of 38 cents, indicating strong profitability and boosting investor confidence.
- Sales Miss: The quarterly sales of $478 million fell short of the expected $486.68 million, highlighting some market demand challenges that could impact future revenue growth.
- Stock Surge: The company's shares jumped 7.9% to $11.05 in pre-market trading, reflecting optimistic market sentiment regarding its future prospects and potentially attracting more investor interest.
- Positive Guidance: Pitney Bowes issued FY26 adjusted EPS guidance with a midpoint above estimates, further strengthening market confidence in its long-term growth potential.
See More
U.S. Stocks Mostly Lower, Nasdaq Drops Over 50 Points
- Market Performance: U.S. stocks traded mostly lower on Tuesday, with the Nasdaq Composite falling over 50 points, and the S&P 500 dropping 0.13% to 6,827.16, indicating a cautious investor sentiment amid market weakness.
- Company Highlights: Medtronic PLC (NYSE:MDT) reported an adjusted EPS of $1.36 for Q3, exceeding market expectations of $1.33, with quarterly sales of $9.017 billion surpassing the $8.905 billion forecast, showcasing the company's strong earnings capability.
- Sector Dynamics: Financial shares gained 0.9%, while materials stocks fell by 2%, reflecting a divergence in market performance as investors may be seeking more defensive investment opportunities amidst volatility.
- Economic Indicators: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, up from 7,750 in the previous period, indicating an improving labor market trend.
See More
Kraig Biocraft Laboratories Shifts to Production Phase
- Production Strategy Shift: Kraig Biocraft Laboratories announced its 2026 production strategy has officially transitioned into execution mode, targeting a monthly output of 10 metric tons of recombinant spider silk cocoons, marking an ambitious scale-up in the advanced materials market.
- Commercialization Progress: This production shift is seen as a pivotal step from planning to production, expected to drive sustainable supply contracts and downstream revenue visibility, thereby enhancing market competitiveness.
- AI Technology Partnership: Gaxos.ai finalized a deal with BytePlus, securing preferred pricing and early access to advanced video generation models, which is anticipated to enhance deployment speed and gross margins for its AI video tools.
- Enterprise Security Expansion: Bond completed a one-year pilot with one of the world's largest employers, and if converted into a broader rollout, it could generate over $10 million in annual revenue, highlighting its growth potential in the corporate security sector.
See More
Gaxos.ai Partners with ByteDance to Enhance AI Capabilities
- Strategic Partnership: Gaxos.ai has finalized a partnership with ByteDance's enterprise technology unit, BytePlus, securing preferred pricing and discounts on advanced video generation models, which will accelerate the integration of AI tools into its Art-Gen platform and significantly enhance market competitiveness.
- Cost Reduction: This collaboration is expected to lower infrastructure costs and improve scalability for Gaxos.ai, which in turn is projected to enhance gross margins and drive profitability across its AI solutions in health, wellness, and gaming sectors.
- Stock Surge: Following the announcement of the partnership with ByteDance, Gaxos.ai's shares surged nearly 55% in opening trades, indicating strong market confidence in the strategic collaboration and reflecting investor optimism about the company's growth potential.
- AWS Funding Support: Gaxos.ai also received funding from Amazon Web Services (AWS) for its AI-powered sales coaching platform, Gaxos Labs, which is expected to enhance platform security and operational efficiency through features like real-time call transcription and automated coaching insights.
See More
U.S. Stocks Show Mixed Performance in Morning Trading
- Dow Jones Index Gains: On Tuesday, the Dow Jones index rose approximately 0.1%, trading up 0.06% to 49,529.45 points after the market opened, indicating a mild optimistic sentiment despite mixed overall performance.
- NASDAQ and S&P 500 Performance: The NASDAQ fell 0.03% to 22,540.83 points, while the S&P 500 gained 0.04% to 6,838.63 points, reflecting a divergence between tech stocks and blue-chip stocks, prompting investors to monitor sector dynamics closely.
- Manufacturing Index Decline: The NY Empire State Manufacturing Index dropped to 7.1 in February from 7.7 in January and below the market estimate of 7, indicating a slowdown in manufacturing activity that could impact overall economic growth expectations.
- Improved Employment Data: According to ADP Research, U.S. private employers added an average of 10,250 jobs per week during the four weeks ending January 31, compared to 7,750 in the prior period, suggesting a gradual recovery in the labor market.
See More
